Kylie Price is the Chief Technology Officer at the Malaghan Institute of Medical Research with 20 years’ experience providing strategic, scientific, and operational direction in multidisciplinary environments. Kylie has strong stakeholder management and engagement skills and has attracted more than $35m of philanthropic funding over the past 13 years, developing the largest and most technologically advanced Shared Resource Laboratory in Aotearoa, New Zealand, the Hugh Green Technology Centre. This is a state-of-the-art, one-stop shop technology centre for the deep understanding of biological systems from the micro- to the macro-level. As CTO Kylie ensures scientists across New Zealand access to some of the most world-leading technology platforms (including full spectrum flow cytometry, histology, bioimaging, data science, genomics and mRNA for pre-clinical vaccine development) to advance their research goals.
Kylie played a pivotal role in supporting the establishment of a ground-breaking $69.5 million national RNA development platform. She has a strong leadership track-record, organising high-profile networking events, such as CYTOAsia Singapore 2017, and directing international organisations, such as the Australasian Cytometry Society of which she is former President (2015-2016). Kylie is a two-time NZ Woman of Influence Awards (2014 and 2018) finalist and finalist of the 2021 NZ High Tech Awards. She was the first New Zealander elected to the International Society for Advancement of Cytometry (ISAC) Council (2018-2020) and served as Chair of the Governance Committee and Secretary of ISAC for four years (2020-2024). Kylie was selected to join the NZ OnBoard Program in April 2023, enhancing her governance and strategic planning skills and she currently serves as a board observer for Orbis Diagnostics and a member of the Advisory Group of Advemto.